Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Marco Chiarini"'
Autor:
Marco Vignetti, Alessandro M. Vannucchi, Francesco Mannelli, Sergio Amadori, Francesco Buccisano, Giacomo Gianfaldoni, Roberto Caporale, Paola Fazi, Maria Teresa Voso, Giuseppe Rossi, Paola Guglielmelli, Adriano Venditti, Enrico Crea, Marco Chiarini, Alfonso Piciocchi
Publikováno v:
Future Oncology. 17:3787-3796
AMELIORATE is a Phase III, randomized trial aiming to personalize treatment intensity in FLT3-mutated acute myeloid leukemia. The current study provides an early appraisal of chemosensitivity based on peripheral blasts clearance, as assessed by multi
Autor:
Giulia Baresi, Mauro Giacomelli, Daniele Moratto, Marco Chiarini, Immacolata Claudia Conforti, Rita Padoan, Piercarlo Poli, Silviana Timpano, Francesca Caldarale, Raffaele Badolato
Publikováno v:
Frontiers in Pediatrics, Vol 9 (2021)
Frontiers in Pediatrics
Frontiers in Pediatrics
Since the beginning of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic, data registered in the European countries revealed increasing cases of infection in cystic fibrosis (CF) patients. In the course of this pandemic, we en
Autor:
Francesca Caldarale, Mauro Giacomelli, Emirena Garrafa, Nicola Tamassia, Alessia Morreale, Piercarlo Poli, Silviana Timpano, Giulia Baresi, Fiammetta Zunica, Marco Cattalini, Daniele Moratto, Marco Chiarini, Elvira Stefania Cannizzo, Giulia Marchetti, Marco Antonio Cassatella, Andrea Taddio, Alberto Tommasini, Raffaele Badolato
Publikováno v:
Frontiers in Immunology, Vol 12 (2021)
Frontiers in Immunology
Frontiers in Immunology
BackgroundSARS-CoV-2 occurs in the majority of children as COVID-19, without symptoms or with a paucisymptomatic respiratory syndrome, but a small proportion of children develop the systemic Multi Inflammatory Syndrome (MIS-C), characterized by persi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b58d292cac3d93304b53e7bd954fa2e3
https://hdl.handle.net/11562/1082809
https://hdl.handle.net/11562/1082809
Autor:
Roberto Caporale, Fabiana Pancani, Maria Ida Bonetti, Matteo Benelli, Barbara Scappini, Orietta Spinelli, Giacomo Gianfaldoni, Damiano Giupponi, Tommaso Rondelli, Vanessa Ponziani, Alessandro Rambaldi, Marco Chiarini, Alberto Bosi, Sara Bencini, Erika Borlenghi, Giuseppe Rossi, Pamela Zanghì, Renato Bassan, Ilaria Cutini, Matteo Piccini, Benedetta Peruzzi, Anna Maria Grazia Gelli, Francesco Mannelli
Publikováno v:
Haematologica
Mutations in CCAAT/enhancer binding protein α (CEBPA) occur in 5–10% of cases of acute myeloid leukemia. CEBPA-double-mutated cases usually bear biallelic N- and C-terminal mutations and are associated with a favorable clinical outcome. Identifica
Autor:
Valeria Cancelli, Giuseppina Ruggeri, Cinzia Lamorgese, Cristina Skert, Viviana Giustini, Enrico Morello, Giuseppe Rossi, Michele Malagola, Marco Chiarini, Federica Cattina, Rossella Ribolla, Simona Bernardi, Chiara Cattaneo, Chiara Pagani, Erika Borlenghi, Domenico Russo, Luisa Imberti, Elisa Cerqui, Angela Passi, Luigi Caimi
Publikováno v:
Cancer Medicine. 5:265-274
Risk stratification in acute myeloid leukemia (AML) patients using prognostic parameters at diagnosis is effective, but may be significantly improved by the use of on treatment parameters which better define the actual sensitivity to therapy in the s
Autor:
Camilla Zanaglio, Valeria Cancelli, Francesca Schieppati, Nicola Polverelli, Marco Chiarini, Alessandro Turra, Viviana Giustini, Enrico Morello, Michele Malagola, Simone Perucca, Domenico Russo, Federica Cattina, Benedetta Rambaldi, Alessandra Sottini, Cristina Skert, Alessandro Montanelli, Simona Bernardi, Luisa Imberti
Two different rabbit anti-thymocyte globulin (ATG) formulations, thymoglobulin-ATG (tATG) and fresenius-ATG (fATG) are usually employed as prophylaxis for graft-versus-host-disease (GVHD), one of t...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::07e58c548bea4d4aa62a7f7d9e5d4ba9
http://hdl.handle.net/11379/507726
http://hdl.handle.net/11379/507726
Autor:
Michele Moschetta, Irene M. Ghobrial, Michelle Kuhne, Salomon Manier, Elizabeth A. Morgan, Michele Cea, Ilyas Sahin, Yu-Tzu Tai, Jiantao Shi, Franziska Michor, Aldo M. Roccaro, Yuji Mishima, Yong Zhang, Daisy Huynh, Siobhan Glavey, Michaela R. Reagan, Yosra Aljawai, Chin Pan, Yawara Kawano, Marco Chiarini, Pina M. Cardarelli, Antonio Sacco
Publikováno v:
Cell Reports, Vol 12, Iss 4, Pp 622-635 (2015)
Extra-medullary disease (EMD) in Multiple Myeloma (MM) is associated with poor prognosis and resistance to chemotherapy. However, molecular alterations that lead to EMD have not been well defined. We developed bone marrow (BM)- and EMD-prone MM synge
Autor:
Viviana Giustini, Michele Malagola, Nicola Polverelli, Federica Cattina, Simona Bernardi, Simone Perucca, Stefano Martellos, Marco Chiarini, Luisa Imberti, Claudia Ghidini, Alessandra Sottini, Cristina Skert, Valeria Cancelli, Alessandro Turra, Domenico Russo, Benedetta Rambaldi
Publikováno v:
PLoS ONE
PLoS ONE, Vol 12, Iss 4, p e0175337 (2017)
PLoS ONE, Vol 12, Iss 4, p e0175337 (2017)
T and B lymphocyte subsets have been not univocally associated to Graft-versus-host disease (GVHD) and relapse of hematological malignancies after stem cell transplantation (SCT). Their sequential assessment together with B and T cell neogenesis inde
Autor:
Angelo Belotti, Alessandro Montanelli, Irene M. Ghobrial, Viviana Giustini, Giuseppe Rossi, Michele Malagola, Alessandra Sottini, Monica Valotti, Yawara Kawano, Marco Chiarini, Antonio Sacco, Federico Serana, Rossella Ribolla, Bruno Paiva, Patricia Maiso, Domenico Russo, Claudia Ghidini, Michaela R. Reagan, Aldo M. Roccaro, Luisa Imberti, Diego Bertoli, Michele Moschetta
Herein we dissect mechanisms behind the dissemination of cancer cells from primary tumor site to the bone marrow, which are necessary for metastasis development, with a specific focus on multiple myeloma. The ability of tumor cells to invade vessels
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::30a3dc21c19ebf2664509c54a34855e7
http://hdl.handle.net/11379/495781
http://hdl.handle.net/11379/495781
Autor:
Alessandro Re, Viviana Giustini, Federico Serana, Luisa Imberti, Alessandra Sottini, Chiara Cattaneo, Giuseppe Rossi, Luigi Caimi, Diego Bertoli, Marco Chiarini, Aldo M. Roccaro
Publikováno v:
Scientific Reports.
Combination of anti-retroviral therapy, high-dose chemotherapy (HCT) and autologous stem cell transplantation (ASCT) has led to an improved survival of HIV+ non-Hodgkin lymphoma (NHL) patients. We compared T- and B-cell subset recovery and related ca